Further analysis of the immune system factors demonstrated that the patients with an immune system equipped with favorable pre-existing or post-vaccination anti-tumor capabilities, such as IFN γ secretion and CD8+ cells, are more likely to live longer [91]. The gene discussed is CD8A; the disease is neoplasm.